Over 56.81 crore Covid vaccine doses provided to states, UTs: Govt

More than 56.81 crore COVID-19 vaccine doses have been provided to states and Union Territories so far through all sources, the Union health ministry said on Monday

Topics
Coronavirus Vaccine | Vaccination | Health Ministry

Press Trust of India  |  New Delhi 

vaccination, coronavirus, covid-19, vaccine
Visitors wait at a government school in Noida to receive Covid-19 vaccine doses. (PTI Photo)

More than 56.81 crore COVID-19 vaccine doses have been provided to states and Union Territories so far through all sources, the Union said on Monday.

Of these, the total consumption, including wastage, is 54,22,75,723 doses, according to the data available at 8 am.

More than 2.89 crore (2,89,47,890) balance and unutilised COVID-19 vaccine doses are still available with the states, UTs, and private hospitals which are yet to be administered, the ministry stated.

The Union government is committed to accelerating the pace and expanding the scope of COVID-19 drive throughout the country, it said.

The new phase of universalisation of COVID-19 commenced from June 21.

The drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to states and UTs for enabling better planning by them, and streamlining the vaccine supply chain, the ministry said.

As part of the nationwide vaccination drive, the government has been supporting the states and UTs by providing them Covid vaccines free of cost.

In the new phase of the universalisation of the vaccination drive, the Union government will procure and supply 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to the states and UTs.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Mon, August 16 2021. 16:32 IST
RECOMMENDED FOR YOU